Filing Flows › Krystal Biotech (KRYS) › Net income
Krystal Biotech (KRYS) net income by quarter
Krystal Biotech's net income was $63.1M in Q3 2026 (third quarter 2026), +15% from Q2 2026. Over the last 7 quarters it ranged from $35.7M (Q1 2025) to $79.4M (Q3 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $63.1M | +15% | -21% |
| Q2 2026 | $54.8M | -2% | +43% |
| Q1 2026 | $55.9M | +9% | +57% |
| Q4 2025 | $51.4M | -35% | — |
| Q3 2025 | $79.4M | +107% | — |
| Q2 2025 | $38.3M | +7% | — |
| Q1 2025 | $35.7M | — | — |
Q3 2026 at a glance
Krystal Biotech, Q3 2026: revenue $127M (+30% year over year), operating margin 55.9%, net earnings $63.1M, operating cash flow $91.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Krystal Biotech's net income?
Krystal Biotech's net income was $63.1M in Q3 2026 (third quarter 2026), +15% from Q2 2026.
How has Krystal Biotech's net income changed?
Over the last 7 quarters it ranged from $35.7M (Q1 2025) to $79.4M (Q3 2025).